Nanomedicines as drug delivery carriers of anti-tubercular drugs: from pathogenesis to infection control

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - ingentaconnect.com
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

[PDF][PDF] Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - research.vit.ac.in
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

[HTML][HTML] Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - ncbi.nlm.nih.gov
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control.

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - europepmc.org
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - hero.epa.gov
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control

A Hussain, S Singh, SS Das… - Current drug …, 2019 - pubmed.ncbi.nlm.nih.gov
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

[PDF][PDF] Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - scienceopen.com
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

[PDF][PDF] Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control

A Hussain, S Singh, SS Das… - Current Drug …, 2019 - pdfs.semanticscholar.org
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

Nanomedicines as drug delivery carriers of anti-tubercular drugs: From pathogenesis to infection control

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - ksascholar.dri.sa
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …

Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control.

A Hussain, S Singh, SS Das, K Anjireddy… - Current Drug …, 2019 - europepmc.org
In spite of advances in tuberculosis (TB) chemotherapy, TB is still airborne deadly disorder
as a major issue of health concern worldwide today. Extensive researches have been …